AssureRx Raises $11M in Series B Round | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – AssureRx Health has closed on an $11 million Series B round of private financing, the Cincinnati-based firm said today.

AssureRx is developing pharmacogenomic tests specifically for neuropsychiatric patients. Its GeneSightRx technology uses DNA from a cheek swab to measure and analyze genetic variants to determine how a patient will respond to psychotropic medications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.